(Press-News.org) The notion that some level of microbial exposure might reduce our risk of developing allergies has arisen over the last few decades and has been termed the hygiene hypothesis. Now, an article published in Science Immunology by researchers from Karolinska Institutet challenges this hypothesis by showing that mice with high infectious exposures from birth have the same, if not an even greater ability to develop allergic immune responses than 'clean' laboratory mice.
How microbes may prevent allergy has been a topic of great interest in recent times. Studies have suggested that certain infections might reduce the production of inflammatory antibodies to allergens and alter the behaviour of T cells involved in allergies. It has also been suggested that good bacteria in our intestines may be able to switch off inflammation in other parts of our body.
Robust allergic responses
Researchers have now compared the allergic immune response in ‘dirty’ wildling mice to those of typical clean laboratory mice. They found very little evidence that the antibody response was altered or that the function of T cells changed in a meaningful way. Nor did anti-inflammatory responses evoked by good gut bacteria appear to be capable of switching off the allergic immune response. On the contrary, wildling mice developed robust signs of pathological inflammation and allergic responses when exposed to allergens.
“This was a little unexpected but suggests that it’s not as simple as saying, ‘dirty lifestyles will stop allergies while clean lifestyles may set them off’. There are probably very specific contexts where this is true, but it is perhaps not a general rule”, says Jonathan Coquet, co-author of the study and Associate Professor at the Department of Microbiology, Tumor and Cell Biology at Karolinska Institutet in Sweden.
More like the human immune system
The wildling mice are genetically identical to clean laboratory mice but are housed under seminatural conditions and have rich microbial exposures from birth.
"The immune systems of wildling mice better represent the human immune system and so we hope that they can bring us closer to the truth of how microbes act upon the body," says Jonathan Coquet.
The findings contribute to our general understanding of how allergies may arise and may also have clinical implications. In clinical trial settings, researchers and clinicians have recently made attempts to treat patients suffering from inflammatory diseases with experimental infections. For example, infecting people with worms or performing faecal transplantations has been proposed as a tool to combat inflammatory diseases. Newborns delivered through C-section, have had maternal faecal transplantation and bacterial supplementation with the aim of promoting good bacteria in the baby’s gut and the child’s future health.
Can provide important insights
“This field of research can provide important insights into how infections and microbes can be used to facilitate health, but it is still in its infancy. Our study is a reminder that general and broad exposures to microbes may not have the clear beneficial effects that we wish them to have”, says Susanne Nylén, co-author of the study and Associate Professor at the Department of Microbiology, Tumor and Cell Biology at Karolinska Institutet.
The work was led by Junjie Ma and Egon Urgard, researchers in Jonathan Coquet's group, and done in close collaboration with Professor Stephan Rosshart at University Medical Center Freiburg in Germany and Susanne Nylén (MTC). Several other research groups at Karolinska Institutet and elsewhere also contributed to this work, including the teams of Assistant professors Itziar Martinez Gonzalez and Juan Du (both at the Department of Microbiology, Tumor and Cell Biology, MTC).
The study was financed by several bodies, including the Swedish Research Council, the Swedish Cancer Foundation, KI intramural funds, and the Wenner-Gren Foundation.
Publication: "Laboratory mice with a wild microbiota generate strong allergic immune responses”, Junjie Ma, Egon Urgard, Solveig Runge, Cajsa H. Classon, Laura Mathä, Julian M. Stark, Liqin Cheng, Javiera Alvarez, Silvia von Zedtwitz, Austeja Baleviciute, Sergio Martinez Hoyer, Muzhen Li, Anne Marleen Gernand, Lisa Osbelt, Agata Anna Bielecka, Till R. Lesker, Huey-Jy Huang, Susanne Vrtala, Louis Boon, Rudi Beyaert, Mikael Adner, Itziar Martinez Gonzalez, Till Strowig, Juan Du, Susanne Nylén, Stephan P. Rosshart, Jonathan M. Coquet, Science Immunology, online 29 September 2023, doi: 10.1126/sciimmunol.adf7702.
Allergy study on 'wild' mice challenges the hygiene hypothesis
ELSE PRESS RELEASES FROM THIS DATE:
Ancient plant wax reveals how global warming affects methane in Arctic lakes
New study makes novel use of plant biomarkers preserved in sediment to reconstruct methane cycling over the past 10,000 years Plant waxes hold an isotopic signature of ancient methane As planet warmed due to slow changes in Earth’s orbit, lakes produced increased amounts of methane, which is a potent greenhouse gas Researcher: ‘Living on a warming planet, we can look to these signs from the past to predict our future’ EVANSTON, Ill. — By studying fossils from ancient aquatic plants, ...
Atopic dermatitis: Viruses discovered as new therapy option
Up to 15 percent of children and five percent of adults are affected by the chronic inflammatory skin disease atopic dermatitis. Despite advanced therapy measures, the severe itching and eczema, especially on the elbows or knees, cause great distress to the patients. In the course of a study conducted at MedUni Wien a research team led by Wolfgang Weninger, Head of the Department of Dermatology, has discovered a new approach: bacteriophages, which colonize the skin as viral components of the microbiome and can drive the development of innovative ...
Larger lymph node threshold optimizes nasopharyngeal carcinoma outcomes
Leesburg, VA, September 29, 2023—According to the American Journal of Roentgenology (AJR), using a 6-mm threshold, rather than a 5-mm threshold, helps facilitate better risk stratification and treatment decisions in patients with nasopharyngeal carcinoma (NPC). “Future American Joint Committee on Cancer (AJCC) staging updates should consider incorporation of the 6-mm threshold for N-category and tumor-stage determinations,” wrote corresponding author Zhiying Liang, MD, from the radiology department at China’s Sun Yat-sen University Cancer Center. This AJR accepted manuscript by Liang et al. included ...
BPS celebrates Max Planck-Humboldt medal awardee Kandice Tanner
ROCKVILLE, MD – The Biophysical Society is honored to celebrate Kandice Tanner, a physicist and Senior Investigator at the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH) in Bethesda, Maryland. Tanner is being recognized for her pioneering work on the biophysics of the metastatic spread of cancer. Using 3D organoid models of cancer progression, Tanner discovered a novel type of cell migration and cell generated forces associated with the formation of microtissues and tumors. This discovery demonstrated that physical forces are important in the establishment ...
Cleveland Clinic researchers develop new model for prioritizing lung transplant candidates
September 29, 2023, CLEVELAND: A team from Cleveland Clinic has developed a new model for prioritizing patients waiting for a lung transplant, aimed at improving outcomes and reducing deaths among those in need of donor lungs. The new method offers an improved strategy for organ allocation by taking into account how the time a patient has spent on the waiting list could impact the severity of their disease and the urgency of their need for a transplant. The results of a study looking at this new method were published today in The American Journal of Respiratory and Critical Care Medicine. Currently, ...
American Academy of Arts and Sciences to induct UVA's Garcia-Blanco
The University of Virginia School of Medicine’s Mariano A. Garcia-Blanco, MD, PhD, will be inducted this weekend into the American Academy of Arts and Sciences (AAAS), one of the country’s oldest and most prestigious honorary societies, in recognition of his exceptional scientific contributions. The AAAS was founded in 1780 – during the Revolutionary War – by John Adams, John Hancock and other founding fathers who wanted to “cultivate every art and science which may tend to advance the interest, honor, dignity and ...
Illinois-led team puts cows and microbes to work to reduce greenhouse gases
URBANA, Ill. — As we hurtle toward crucial tipping points on a warming planet, an international team of scientists is recruiting a surprising ally to make a powerful dent in greenhouse gas emissions: the cow. Animal sciences researchers from the University of Illinois Urbana-Champaign are driving a new project to reduce methane production resulting from rumen fermentation in beef and dairy cattle. The 3-year, $3.2-million project is part of the Greener Cattle Initiative, led by the Foundation for Food and Agriculture Research (FFAR). According to the researchers, aggressively targeting methane could help course-correct our climate trajectory on a quicker timeline ...
DOE announces $264 million for basic research in support of Energy Earthshots™
WASHINGTON, D.C. — The U.S. Department of Energy (DOE) today announced $264 million in funding for 29 projects to develop solutions for the scientific challenges underlying DOE’s Energy Earthshots™ Initiative to advance clean energy technologies within the decade. The funding will support 11 new Energy Earthshot Research Centers led by DOE National Laboratories and 18 university research teams addressing one or more of the Energy Earthshots™ that are focused on six different areas, including industrial decarbonization, carbon storage, and offshore wind. The Department launched the Energy Earthshots ...
New drug a breakthrough for brain tumor that strikes young people: NEJM editorial
A top UVA Health cancer expert is highlighting how a new drug could transform how doctors treat a brain tumor that typically strikes younger people. David Schiff, MD, the co-director of UVA Cancer Center’s Neuro-Oncology Center, has authored an editorial in the prestigious New England Journal of Medicine describing the potential significance of the drug vorasidenib for patients with tumors known as “grade 2 IDH-mutant gliomas.” The drug, when tested in the INDIGO clinical trial, was found to slow tumor growth significantly and extended the average time until the tumor started growing from 11.1 months ...
Genome study reveals 30 years of Darwin’s finch evolution
An international team of researchers has released a landmark study on contemporary evolutionary change in natural populations. Their study uses one of the largest genomic datasets ever produced for animals in their natural environment, comprising nearly 4,000 Darwin’s finches. The study has revealed the genetic basis of adaptation in this iconic group. The results are published in the journal Science. Ever since Darwin wrote about the finches of the Galápagos Islands, biologists have studied these small songbirds to understand the mechanisms of evolution. One ancestral species has evolved into 18 different species in the last million years. ...